Complications

Oncology

17 drugs in development·16 companies·1 clinical trial

Drug Pipeline by Phase

Approved(13)

Drug	Company
cnj-016	Emergent BioSolutions Inc. (EBS)
diclofenac	Miromatrix Medical Inc. (MIRO)
dipyridamole	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
elupro	ELUTIA INC. (ELUT)
enoxaparin	Amphastar Pharmaceuticals, Inc. (AMPH)
epidiolex	Jazz Pharmaceuticals plc (JAZZ)
fluphenazine	DR REDDYS LABORATORIES LTD (RDY)
heparin	PFIZER INC (PFE)
perphenazine	Mylan II B.V. (MYL)
prochlorperazine edisylate	NEXUS BIOPHARMA INC (NEXS)
propylgallate	CHINA PHARMA HOLDINGS, INC. (CPHI)
Propylgallate for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
thiothixene	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(1)

Drug	Company
Dalargin	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 1(1)

Drug	Company
C-reactive protein and procalcitonin dosages	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(2)

Drug	Company
ic 100	ZyVersa Therapeutics, Inc. (ZVSA)
phoenix metabolic	Phoenix Life Sciences International Limited. (PLSI)

BioSniper tracks 17 drugs in development for Complications across 16 companies.

There are 1 clinical trial targeting Complications tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.